Science AI Journal
Medicine · Research topic

Open research questions in Parathyroid Disorders and Treatments

536 gap statements mined from Parathyroid Disorders and Treatments papers in our 7.9M-paper local library, which holds 2,215 papers on the topic — drawn mostly from each paper's own stated research gap, future-work, challenge and limitation notes, and its abstract. The ones listed below are a selection still marked open; each names the study that raised it, with a DOI link where the paper has one.

Choosing where to publish on Parathyroid Disorders and Treatments? See the ranked Medicine journals.

What the literature leaves open

  • The mechanisms underlying high-phosphate-induced calcification in human aortic smooth muscle cells are not fully understood. The role of NRF2-associated antioxidant signalling in vascular calcification is not well established.

    Jiedu Quyu Ziyin Decoction attenuates high-phosphate-induced calcification-associated phenotypes in cultured human aortic smooth muscle cells · 2026 · DOI

  • Assessing vascular calcification in clinical practice remains challenging due to limitations of computed tomography and chest x-ray. Identifying individuals at high risk of vascular calcification is crucial for preventing adverse cardiovascular outcomes. Developing a clinically applicable risk assessment model that incorporates D-dimer and other relevant factors.

    Association of D-dimer levels with vascular calcification in patients undergoing maintenance hemodialysis: a cross-sectional study · 2026 · DOI

  • Lack of therapeutic options for prevention or treatment of vascular calcification. Limited understanding of the complex mechanisms underlying vascular calcification. Need for consistent models and standardization of assays and reporting in vascular calcification research.

    Considerations on the Development of Therapeutics in Vascular Calcification · 2025 · DOI

  • Further studies are needed to validate the findings in a larger patient population. Research is needed to explore the mechanisms by which FGF23 predicts postoperative outcomes. Studies should investigate the potential of FGF23 as a therapeutic target to improve outcomes after LVAD implantation.

    Fibroblast Growth Factor 23 Is a Strong Predictor of Adverse Events After Left Ventricular Assist Device Implantation · 2025 · DOI

  • There is a need for a comprehensive review of recent data on PHPT in MEN2. Prior studies have limitations in terms of sample size and study design. There is a gap in understanding the clinical presentation and surgical outcomes of PHPT in MEN2 patients.

    An Analysis of Primary Hyperparathyroidism in Individuals Diagnosed with Multiple Endocrine Neoplasia Type 2 · 2025 · DOI

  • The need for empirical treatment due to the unknown cause of hypercalcemia.

    Hypercalcemia Following Adrenalectomy for Cushing Syndrome in a Patient with Post-Surgical Hypoparathyroidism · 2025 · DOI

  • The gap in current understanding is the role of GCLm in regulating vascular smooth muscle cell calcification. The study aims to address this gap by investigating the hypothesis that GCLm may influence vascular calcification through mechanisms that include loss of SMC differentiation.

    Calcification in Vascular Smooth Muscle Cells Is Associated with Elevated GCLm and Impaired Contraction: Insights into Osteogenic Transdifferentiation and Therapeutic Approaches · 2025 · DOI

  • The initial causative events of CKD-associated sarcopenia on a molecular and cellular level are not well understood. The mechanisms mediating tissue maintenance versus repair and driving the initiation versus the progression of damage in CKD-associated sarcopenia are not clear.

    Skeletal Muscle Injury in Chronic Kidney Disease—From Histologic Changes to Molecular Mechanisms and to Novel Therapies · 2024 · DOI

  • The exact mechanisms of FGF23's non-classical effects are not fully understood. The relationship between FGF23 and various diseases, such as cardiovascular disease and obesity, requires further research. The potential side effects of FGF23 inhibition need to be explored.

    Non-Classical Effects of FGF23: Molecular and Clinical Features · 2024 · DOI

  • The limited availability of hospital resources necessitates a simple yet highly predictive evaluation method for postoperative adverse events. The recent integration of biomarkers with recognized risk models has enabled higher predictive performance regarding postoperative complications, but further research is needed.

    Fibroblast Growth Factor 23 Is a Strong Predictor of Adverse Events After Left Ventricular Assist Device Implantation · 2025 · DOI

  • D-dimer, a marker of coagulation and fibrinolysis, may reflect pathophysiological processes linked to VC, but its relationship with VC in MHD patients remains unclear.

    Association of D-dimer levels with vascular calcification in patients undergoing maintenance hemodialysis: a cross-sectional study · 2026 · DOI

  • Future research could explore these aspects to improve the long-term efficacy of CyberKnife treatment for parathyroid adenomas.

    CyberKnife Radiotherapy: A Novel Approach for Refractory Secondary Hyperparathyroidism in Dialysis Patients—A Case Report · 2026 · DOI

  • Whether reduced phosphorus balance or calcium balance with lanthanum carbonate is associated with beneficial clinical outcomes in CKD warrants further investigation.

    Effects of Lanthanum Carbonate on Whole-Body Phosphorus and Calcium Balance in Adults With Chronic Kidney Disease and Normophosphatemia · 2026 · DOI

  • It remains unclear whether hypophosphatemia is transient or persistent, and its underlying mechanism is unknown.

    Persistent Hypophosphatemia in Gitelman Syndrome: A Cohort Study on Prevalence and Associated Factors · 2026 · DOI

  • Parathyroid carcinoma is rare, and its epidemiological relationship to non-cancer primary hyperparathyroidism, along with the comparative long-term cardiometabolic burden of both conditions, remains poorly characterized at the population level.

    Parathyroid carcinoma and primary hyperparathyroidism: trends and outcomes · 2026 · DOI

  • Physical growth is limited to a specific period, and missed interventions may cause lifelong growth retardation.

    Growth Failure Associated With Parathyroid Hormone Levels in Pediatric Dialysis Patients: A Nationwide Cohort Study · 2025 · DOI

  • Previous studies have shown that XLH is associated with worse health-related quality of life (HRQoL) and greater economic burden for children and their families compared with the general population, but evidence from China is scarce.

    Disease burden and health-related quality of life among children with X-linked hypophosphataemia in China: a national cross-sectional survey · 2025 · DOI

  • The natural polyphenol epigallocatechin-3-gallate (EGCG) has been demonstrated to protect against cardiovascular disease; however, whether EGCG supplementation inhibits MAC in CKD remains unclear.

    Epigallocatechin-3-gallate inhibits osteogenic differentiation of vascular smooth muscle cells through the transcription factor JunB · 2024 · DOI

  • This study had a relatively small sample size and short treatment and follow-up period.

    Safety, Pharmacokinetics, and Pharmacodynamics of SHR6508, a Calcium-Sensing Receptor Agonist, in Maintenance Hemodialysis Patients With Secondary Hyperparathyroidism: A Multicenter, Randomized, Double-Blind, Placebo-Controlled Phase 1 Study · 2026 · DOI

  • Parathyroid carcinoma (PC) is a rare but clinically aggressive endocrine malignancy with limited treatment options and a poorly defined tumor microenvironment (TME).

    Single-cell and spatial transcriptomics define a progenitor subpopulation and fibroinflammatory niche at the leading edge of parathyroid carcinoma · 2026 · DOI

  • Initial renal biochemical evaluations were suggestive of proximal tubulopathy; however, secondary investigations were inconclusive.

    McCune-Albright Syndrome as a Rare Cause of Fanconi Syndrome and Kidney Failure: A Case Report and Literature Review · 2025 · DOI

  • Lacked data on recombinant human growth hormone use and limited follow-up periods to evaluate the impact of PTH on long-term growth.

    Growth Failure Associated With Parathyroid Hormone Levels in Pediatric Dialysis Patients: A Nationwide Cohort Study · 2025 · DOI

  • Laboratory studies have demonstrated that mice with α-klotho gene deficiency experience a shortened lifespan, but epidemiological evidence linking circulating α-klotho levels and mortality remain inconclusive.

    Higher Circulating Alpha-klotho Levels Increase All-cause Mortality Through Mediation Effects of Liver Fibrosis: A Second Analysis of National Health and Nutrition Examination Survey · 2025 · DOI

  • Explore normocalcemic PHPT in the context of MEN2-PHPT, - Analyze non-classical features of PHPT in MEN2-PHPT, - Investigate the clinical and therapeutic implications of intraoperative auto-fluorescence in MEN2 patients, - Examine the use of intraoperative indocyanine green angiography for glands localization…

    An Analysis of Primary Hyperparathyroidism in Individuals Diagnosed with Multiple Endocrine Neoplasia Type 2 · 2025 · DOI

  • Future efforts are needed to assess whether a risk-based approach, including VC screening, improves survival, - The study suggests the need for further research on the relationship between carotid VC and mortality in HD…

    The Severity of Carotid Calcifications, but Not Fibroblast Growth Factor 23, Is Associated with Mortality in Hemodialysis: A Single Center Experience · 2025 · DOI

Most-cited papers in Parathyroid Disorders and Treatments

Most recent work

Find a gap in your own Parathyroid Disorders and Treatments sub-topic

This page shows what the Parathyroid Disorders and Treatments literature already flags as unresolved. To narrow it to your specific question, search the Research Gap Finder: the search is free with a free account and lists the papers closest to your topic first. Unlocking that topic (50 credits, charged once) fills the comparison table from our 7.9M-paper local library and writes the gaps from its rows.

Open the Research Gap Finder →

Related topics in Medicine

Artificial Intelligence in Healthcare and Education
4,200 open questions
Dementia and Cognitive Impairment Research
2,789 open questions
Substance Abuse Treatment and Outcomes
2,285 open questions
Cancer Immunotherapy and Biomarkers
2,273 open questions
Liver Disease Diagnosis and Treatment
2,102 open questions
Sports Performance and Training
1,952 open questions
Parkinson's Disease Mechanisms and Treatments
1,915 open questions
Mosquito-borne diseases and control
1,849 open questions
Open questions raised by papers listed on this page include: (1) The mechanisms underlying high-phosphate-induced calcification in human aortic smooth muscle cells are not fully understood (“Jiedu Quyu Ziyin Decoction attenuates high-phosphate-induced…”, 2026); (2) D-dimer, a marker of coagulation and fibrinolysis, may reflect pathophysiological processes linked to VC, but its relationship with VC in MHD patients remains unclear (“Association of D-dimer levels with vascular calcification in patients…”, 2026); (3) Future research could explore these aspects to improve the long-term efficacy of CyberKnife treatment for parathyroid adenomas (“CyberKnife Radiotherapy: A Novel Approach for Refractory Secondary…”, 2026); (4) It remains unclear whether hypophosphatemia is transient or persistent, and its underlying mechanism is unknown (“Persistent Hypophosphatemia in Gitelman Syndrome: A Cohort Study on Prevalence…”, 2026); (5) Lack of therapeutic options for prevention or treatment of vascular calcification (“Considerations on the Development of Therapeutics in Vascular Calcification”, 2025). 536 gap statements have been mined from Parathyroid Disorders and Treatments papers in our 7.9M-paper local library, which holds 2,215 papers on the topic; the gaps come from whichever of those papers state one. They are mostly the research gaps the authors state and the papers' abstracts, plus future-work, limitations and challenges passages. The ones listed below are a selection still marked open; each names the study that raised it, with a DOI link where the paper has one, so you can read the original claim in context.

Tools for your next paper

Gaps & Literature SearchFind open questions in any field — 1,100,000+ open gaps mined from our own library.Pre-CheckIs your paper ready? Acceptance odds for top, mid and open/emerging journals, in seconds.Journal FinderA ranked shortlist of target journals from a 17,500-venue index.Duplicate Publication CheckerCheck for prior publication across 7 sources and our local library.Citation GeneratorFreeA DOI or title → APA, MLA, Vancouver, Chicago, BibTeX, RIS. No signup.Graphical Abstract MakerFreeTurn your findings into a colorblind-safe graphical abstract.

How Pre-Check worksHow AI Review works

Compare the category — Honest roundups of the AI research tools, ours listed alongside the alternatives.

Command palette

Jump anywhere, run any action.